Science & Enterprise subscription

Follow us on Twitter

  • A biotechnology company is developing treatments for cancer and other diseases using Crispr gene editing delivered… https://t.co/cZ13M2gPJk
    about 19 hours ago
  • New post on Science and Enterprise: Biotech Creating More Efficient Crispr Therapies https://t.co/JAfb7hBMoH #Science #Business
    about 19 hours ago
  • I have a Mode joke. It was a Moderna joke, but a messenger lost the RNA.
    about 2 days ago
  • Behind the scenes, CEPI and BARDA were funding vaccine development and covering manufacturing costs. They helped ge… https://t.co/4F5vMbVsrK
    about 3 days ago
  • A YouGov survey taken earlier this month indicates the U.S. public largely supports rejoining the Paris climate agr… https://t.co/eJd2v8G7K8
    about 3 days ago

Please share Science & Enterprise

We like comments, but …

Like other bloggers, we really like comments. But also like many other bloggers, we review all comments before publishing them. Here are a few guidelines to help get your comments published on this blog.

  • Keep them short. We keep most of our blog posts to a few sentences, so we like comments to do the same.
  • Keep them relevant. If your comment does not refer even indirectly to the blog post on which the comment is made, don’t expect it to be published.
  • Keep them civil. All of our blog posts are respectful and businesslike. Take your profanity and bad manners elsewhere.

Comments are closed.